I agree that this site is using cookies. You can find further informations here.
X
Sohn, Joohyuk
171  results:
Search for persons X
?
1

A nationwide real-world study for evaluation of effectivene..:

Baek, Sun Kyung ; Jeong, Jae-ho ; Jung, KyungHae...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
2

Reversion of pathogenic BRCA1 L1780P mutation confers resis..:

Jo, Se-Young ; Lee, Jeong Dong ; Won, Jeongsoo...
iScience.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiti..:

Park, Sanghyun ; Ryu, Won-Ji ; Kim, Tae Yeong...
Experimental & Molecular Medicine.  56 (2024)  4 - p. 987-1000 , 2024
Link: https://doi.org/10.1038/..
 
?
4

IL-7-primed bystander CD8 tumor-infiltrating lymphocytes op..:

Lee, Kun-Joo ; Choi, Donghoon ; Tae, Nara...
Cell Reports Medicine.  5 (2024)  5 - p. 101567 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Pemetrexed plus vinorelbine versus vinorelbine monotherapy ..:

Lee, Dae-Won ; Jung, Kyung Hae ; Lee, Kyung-Hun...
European Journal of Cancer.  197 (2024)  - p. 113456 , 2024
Link: https://doi.org/10.1016/..
 
?
6

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:

Bardia, Aditya ; Jhaveri, Komal ; Kalinsky, Kevin...
Future Oncology.  20 (2024)  8 - p. 423-436 , 2024
Link: https://doi.org/10.2217/..
 
?
7

Supplementary Figure S3 from Phase Ia/b Study of Giredestra..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232186.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
8

Supplementary Table S4 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232174.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
9

Supplementary Table S1 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232183.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
10

Supplementary Figure S1 from Phase Ia/b Study of Giredestra..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232192.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
11

Supplementary Figure S2 from Phase Ia/b Study of Giredestra..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232189.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Supplementary Table S3 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232177.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

Supplementary Table S2 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232180.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Supplementary Table S5 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232171.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
15

Ten-year survival of neoadjuvant dual HER2 blockade in pati..:

Nuciforo, Paolo ; Townend, John ; Piccart, Martine J....
European Journal of Cancer.  181 (2023)  - p. 92-101 , 2023
Link: https://doi.org/10.1016/..
 
1-15